Laserfiche WebLink
4 <br />5 <br />FINAL AGREEMENT 3.25.22 <br />Research on novel harm reduction and prevention efforts such as the <br />provision of fentanyl test strips. <br />Research on innovative supply-side enforcement efforts such as improved <br />detection of mail-based delivery of synthetic opioids. <br />Expanded research on swift/certain/fair models to reduce and deter opioid <br />misuse within criminal justice populations that build upon promising <br />approaches used to address other substances (e.g.,Hawaii HOPE and <br />Dakota 2417). <br />Epidemiological surveillance of OUD-related behaviors in critical <br />populations, including individuals entering the criminal justice system, <br />including, but not limited to approaches modeled on the Arrestee Drug <br />Abuse Monitoring ("ADAM') system. <br />Qualitative and quantitative research regarding public health risks and <br />harm reduction opportunities within illicit drug markets, including surveys <br />of market participants who sell or distribute illicit opioids. <br />Geospatial analysis of access barriers to MAT and their association with <br />treatment engagement and treatment outcomes. <br />6 <br />7 <br />8 <br />9 <br />E-15